136 related articles for article (PubMed ID: 1329915)
21. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
22. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model.
Rezkalla S; Khatib R; Khatib G; Smith F; Walsh M; Sowers J; Kloner R
J Lab Clin Med; 1988 Jul; 112(1):118-21. PubMed ID: 2839587
[TBL] [Abstract][Full Text] [Related]
23. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
[TBL] [Abstract][Full Text] [Related]
24. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
25. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
Okada I; Matsumori A; Tomioka N; Kawai C
J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
[TBL] [Abstract][Full Text] [Related]
26. [Virus demonstration and pathologic changes in different phases of coxsackievirus B myocarditis in mice].
Rabausch-Starz I; Neu N; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():398-403. PubMed ID: 1708625
[TBL] [Abstract][Full Text] [Related]
27. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
Khatib R; Reyes MP; Khatib G; Giraldo A
Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of chronic myocarditis in mice infected with coxsackie B3 viruses.
Jaśkiewicz K
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):89-97. PubMed ID: 220933
[TBL] [Abstract][Full Text] [Related]
29. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
30. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
31. Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3.
Hashimoto I; Hagiwara A
Br J Exp Pathol; 1986 Feb; 67(1):43-53. PubMed ID: 3947534
[TBL] [Abstract][Full Text] [Related]
32. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
[TBL] [Abstract][Full Text] [Related]
33. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.
Ilbäck NG; Fohlman J; Slorach S; Friman G
J Immunol; 1989 May; 142(9):3225-8. PubMed ID: 2540239
[TBL] [Abstract][Full Text] [Related]
34. The effects of NK4 on viral myocarditis mice.
Shen D; Tang Q; Huang Z; Chen Y; Xiong R; Wu H; Huang J; Feng S; Yan L; Bian Z
Cardiovasc Pathol; 2009; 18(6):323-31. PubMed ID: 19150247
[TBL] [Abstract][Full Text] [Related]
35. Murine natural killer cells limit coxsackievirus B3 replication.
Godeny EK; Gauntt CJ
J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
[TBL] [Abstract][Full Text] [Related]
36. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice.
Matsumori A; Tomioka N; Kawai C
Am Heart J; 1988 Jun; 115(6):1229-32. PubMed ID: 2837073
[TBL] [Abstract][Full Text] [Related]
38. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
39. [A pathologic and ultrastructural study of Coxsackie B3 myocarditis in mice].
Lin JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Jun; 16(3):159-60. PubMed ID: 2851428
[No Abstract] [Full Text] [Related]
40. Intracellular viral localization in murine coxsackievirus-B3 myocarditis. Ultrastructural study by electron microscopic in situ hybridization.
Ukimura A; Deguchi H; Kitaura Y; Fujioka S; Hirasawa M; Kawamura K; Hirai K
Am J Pathol; 1997 Jun; 150(6):2061-74. PubMed ID: 9176398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]